Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Regeneron Pharmaceuticals, Inc.
Type
Public
Traded as NASDAQ: REGN
Industry Pharmaceuticals; Biotech
Founded 1988
Headquarters Tarrytown, New York, US (Headquarters)
Area served
Worldwide
Key people
  • Leonard Schleifer (CEO)
  • George Yancopoulos, CSO
Revenue
  • Increase US$ 2,104.745 million (2013)
  • Increase US$ 1,378.477 million (2012)
Operating income
  • Increase US$ 760.028 million (2013)
  • Increase US$ 457.713 million (2012)
Net income
  • Decrease US$ 424.362 million (2013)
  • Increase US$ 750.269 million (2012)
Total assets
  • Increase US$ 2,951.013 million (2013)
  • Increase US$ 2,080.49 million (2012)
Total equity
  • Increase US$ 1,952.076 million (2013)
  • Increase US$ 1,245.385 million (2012)
Website www.regeneron.com

Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.

Investment goal date:
Dividends reinvested
Regeneron Pharmaceuticals, Inc. REGN report Q2 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q4 2017
2018-01-31
--
--
Q3 2017
2017-11-08
--
--
Q2 2017
2017-08-03
4.1700
3.3400
Q1 2017
2017-05-04
2.9200
2.1600
Q4 2016
2017-02-09
3.0400
2.1900
Q3 2016
2016-11-04
3.1300
2.2700
Q2 2016
2016-08-04
2.8200
1.6900
Q1 2016
2016-05-05
2.5700
1.5900
Q4 2015
2016-02-09
2.8300
1.3400
Q3 2015
2015-11-04
3.4700
1.8200
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
Artisan Partners Limited Partnership
1933228
BANK OF AMERICA CORP /DE/
1193674
BlackRock Fund Advisors
2447609
BlackRock Inc.
6146861
BlackRock Institutional Trust Company, N.A.
2037231
Capital World Investors
7085521
FMR LLC
6623692
JANUS CAPITAL MANAGEMENT LLC
1317162
LOOMIS SAYLES & CO L P
1723483
POLEN CAPITAL MANAGEMENT LLC
1477907
PRICE T ROWE ASSOCIATES INC /MD/
1111875
SANDS CAPITAL MANAGEMENT, LLC
2933444
STATE STREET CORP
3380151
Vanguard Group, Inc
5121496
WELLINGTON MANAGEMENT CO LLP
6135559
Major Shareholders
Name Relationship
Total Shares
Holding stocks
REGENERON PHARMACEUTICALS INC
1.8300% (1809098)
AAVL / REGN /
VAGELOS P ROY
0.3300% (329543)
REGN /
SANOFI-AVENTIS
23.8600% (23641744)
ALNY / KBIO / REGN / RGLS /
RYAN ARTHUR F
0.0400% (39500)
CFG / JTPY / REGN /
SCHLEIFER LEONARD S
0.1600% (157409)
REGN /
BAKER CHARLES A
0.0100% (9000)
PGNX / REGN /
SING GEORGE L
0.1200% (119772)
REGN /
GILMAN ALFRED G
0.0100% (8912)
LLY / REGN /
GOLDSTEIN JOSEPH L
0.0100% (13000)
REGN /
GOLDBERG MURRAY A
0.0700% (64436)
AERI / REGN /
STAHL NEIL
0.0200% (23950)
REGN /
YANCOPOULOS GEORGE
0.0700% (67976)
REGN /
LAROSA JOSEPH J
0.0200% (16756)
REGN /
Terifay Robert J
0.0200% (23293)
REGN /
McCorkle Douglas S
0.0100% (6866)
REGN /
Tessier-Lavigne Marc
0.0100% (6187)
AGIO / PFE / REGN /
% ()